Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 |
|---|---|---|---|---|---|---|
| 1 | BYDUREON | - | - | - | - | 2件: 6 6, 17 💬
|
| 2 | Bydureon 2 mg powder and solvent for prolonged-release suspension | - | - | - | - | 1件: 6 6 💬
|
| 3 | Exenatide extended release 2mg (Bydureon) | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
| 4 | Exenatide Pen Injector [Bydureon] | 1件: Exenatide Exenatide | 1件: Exenatide
Exenatide
💬
| 1件: GLP1R GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 17 17 💬
|